SELF-TEST FOR SARS-COV-2 ANTIGEN (CORONAVIRUS) - ANVISA Registration 81403780003

Access comprehensive regulatory information for SELF-TEST FOR SARS-COV-2 ANTIGEN (CORONAVIRUS) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 81403780003 and manufactured by BEIJING LEPU MEDICAL TECHNOLOGY CO., LTD. The registration is held by ARQUIMED DISTRIBUIDORA E REPRESENTACAO DE PRODUTOS MEDICOS LTDA with validity until Mar 21, 2032.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including HANGZHOU ALLTEST BIOTECH CO. LTD, GENRUI BIOTECH INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.